[ Pharmaceutical Sciences Asia - ONLINE ]
Print ISSN 2586-8195 E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

Pharm Sci Asia ; 41(2),
 

Bioequivalence Study of Sildenafil 20 mg Tablets in Healthy Thai Male Volunteers

B. Chuasuwan*, P. Ratnatilaka Na Bhuket, W. Supasena, C. Manamuti, I. Techatanawat, P. Narakorn, A. Rojanawiwat, and A. Eksaengsri

-


The present study aims to evaluate the bioequivalence of the generic formulation, sildenafil GPO 20 mg tablets to the originator, Revatio® 20 mg tablets. The study was a randomized, single dose, two-way, cross-over, open-label study which included 32 healthy Thai male volunteers under fasting conditions with a 7-day washout period. After drug administration, blood samples have been collected at the predefined time points and the plasma concentrations of sildenafil and its metabolite, piperazine N-desmethylsildenafil, were analyzed using validated LC-MS/MS method. The pharmacokinetic parameters assessed were area under the plasma concentration time curve from time 0 hour to 24 hours (AUC0-24), AUC from time zero to infinity (AUC0-∞), the peak plasma concentration (Cmax), and time to achieve the Cmax (tmax). The geometric mean (90% CI) values for the ratio of AUC0-24, AUC0-∞ and Cmax of the test product over those of the reference product were 101.0% (92.0-110.9%), 100.8% (92.1-110.4%) and 100.9% (90.0-113.1%) for sildenafil, respectively. The geometric mean ratios (90% CI) for piperazine N-desmethylsildenafil were 100.6% (95.1-106.4%), 99.8% (95.2-104.6%), and 100.8% (92.0-110.3%) for AUC0-24, AUC0-∞ Cmax, respectively. The differences between the test and reference product in tmax values were not statistically significant (P>0.05). The 90% confidence intervals of the test/reference AUC ratio and Cmax ratio of sildenafil and piperazine N-desmethylsildenafil were within the acceptance range for bioequivalence. There was no adverse event observed during this bioequivalence study. Both formulations were equivalent in terms of extent and rate of absorption.


Keyword:

Pulmonary arterial hypertension, Phosphodiesterase-5 inhibitor, Bioequivalence, Sildenafil, Pharmacokinetics




Download full paper (PDF File size: 1,590.76 KB.)





Vol.41
No.4
October - December 2014

See other volume

 


Vol.41
No.3
July - September 2014

See other volume

 


Vol.41
No.2
April - June 2014

See other volume

 


Vol.41
No.1
January - March 2014

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University
Member's menu

You're now loging on with following account:
Guest (unknown)

Please Sign in or Register



    Copyright © 2017
    Faculty of Pharmacy, Mahidol University, THAILAND